Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks

Por Squires, Kathleen E, Young, Benjamin, Santiago, Lizette, Dretler, Robin H, Walmsley, Sharon L, Zhao, Henry H, Pakes, Gary E, Ross, Lisa L, Shaefer, Mark S
Publicado no HIV AIDS (Auckl) (2017)

Inflammatory Biomarker Changes and Their Correlation with Framingham Cardiovascular Risk and Lipid Changes in Antiretroviral-Naive HIV-Infected Patients Treated for 144 Weeks with...

Por Young, Benjamin, Squires, Kathleen E., Ross, Lisa L., Santiago, Lizette, Sloan, Louis M., Zhao, Henry H., Wine, Brian C., Pakes, Gary E., Margolis, David A., Shaefer, Mark S.
Publicado em 2013

318. Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) in Hispanic/Latinx and Black Participants: Efficacy, Bone and Renal Safety Results from a Pooled Analysis o...

Por DeJesus, Edwin, Federico Andrade Villanueva, Jaime, Ramon Arribas Lopez, Jose, Brinson, Cynthia, Crofoot, Gordon, Daar, Eric S, Koenig, Ellen, Podzamczer, Daniel, Ramgopal, Moti, Santana, Jorge, Santiago, Lizette, Tebas, Pablo, Zorrilla, Carmen, Guo, Susan, Liu, Ya-Pei, Zhong, Lijie, Brainard, Diana M, Carter, Christoph C, Temme, Lauren, Das, Moupali
Publicado no Open Forum Infect Dis (2019)